GGrantIndex
← Leaderboards

Shehnaz Khursheed Hussain

University Of California Los Angeles

$5,082,198
Attributed
$5,082,198
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201024
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,082,198 · 5

By mechanism

R01$3,800,208 · 2
K07$623,335 · 1
R21$358,655 · 1
R56$300,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Incidence

Research focus

IncidenceEpidemiologyCohortSerumHigh RiskEtiologyMolecularLogistic RegressionsPathway InteractionsBiological MarkersProspectiveBlood SpecimenB-LymphocytesCohort StudiesLiver CirrhosisMortalityChronicNested Case-Control StudyCxcl13 GeneDesignLiverMemberB-Cell ActivationCirrhosis

Grant awards (19)

Epidemiology of the gut-liver axis and hepatocellular carcinoma risk in a multiethnic liver cirrhosis cohort: defining the role of bacteria, metabolites, and glycoproteins$300,000
R56 · FY2024 · CA · contact PI
Gut-Related markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$371,434
R01 · FY2020 · CA · contact PI
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$45,178
R01 · FY2020 · CA · contact PI
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation$637,024
R01 · FY2019 · CA · contact PI
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$265,774
R01 · FY2019 · CA · contact PI
Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease$109,071
R21 · FY2019 · CA · contact PI
Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease$73,070
R21 · FY2019 · CA · contact PI
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation$661,266
R01 · FY2018 · CA · contact PI
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$260,399
R01 · FY2018 · CA · contact PI
Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease$176,514
R21 · FY2018 · CA · contact PI
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation$697,142
R01 · FY2017 · CA · contact PI
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$421,173
R01 · FY2017 · CA · contact PI
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort$440,818
R01 · FY2016 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$125,207
K07 · FY2014 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$93,933
K07 · FY2013 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$31,275
K07 · FY2013 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$125,208
K07 · FY2012 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$125,208
K07 · FY2011 · CA · contact PI
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma$122,504
K07 · FY2010 · CA · contact PI